TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/21/22 17:12 | 6/13/22 | MTEM | Molecular Templates, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lalande Kevin M. | TX | DT | P.m | 198 | 0.8936 | 0 | 222 | 3 | 7,234 | I | |||||||||||||||
9/10/21 16:57 | 9/8/21 | LUMO | Lumos Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lalande Kevin M. | TX | D | P | 112 | 11.21 | 0 | 10 | 1 | 732 | I | |||||||||||||||
9/7/21 17:56 | 9/2/21 | LUMO | Lumos Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lalande Kevin M. | TX | D | P.m | 274 | 11.22 | 0 | 24 | 4 | 722 | I | |||||||||||||||
9/1/21 18:46 | 8/30/21 | LUMO | Lumos Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lalande Kevin M. | TX | D | P.m | 205 | 10.66 | 0 | 19 | 3 | 697 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |